| Project Title | Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate |
| Date Posted | Monday, March 19, 2018 |
| Project ID | TO16_CAP_STR_WP001-002_NSDP_V01 |
| Status | Complete |
| Deliverables | |
| Description | These reports investigate counts and prevalent use of drug products and procedures in the Mini-Sentinel Distributed Database (MSDD). Report 1 includes prevalence of 11 drug products and Report 2 includes counts and prevalence of 11 Healthcare Common Procedure Coding System (HCPCS) procedure codes. Results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on October 30, 2014 to 14 Data Partners; this report includes information from 14 Data Partners. |
| Medical Product | alendronate sodium alendronate sodium/vitamin d3 bandronate sodium calcitonin salmon calcitonin, salmon, synthetic denosumab ibandronate sodium raloxifene HCL risedronate sodium risedronate sodium/calcium carbonate teriparatide zoledronic acid zoledronic acid reclast zoledronic acid/mannitol and water zoledroniccid reclast zoledroniccid zometa |
| Population / Cohort | All individuals |
| Time Period | 2006-2014 |
| Assessment Type | Exploratory Analyses |
| Study Type | Summary Table |
| Data Sources | Mini-Sentinel Distributed Database (MSDD) |
| FDA Center | CDER |
